3Lodise TP,McKinnon PS.Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia[J].Diagn Microbiol Infect Dis,2005;52(2):113-22.
4Daniel A,Euler C,Collin M,et al.Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant staphylococcus aureus[J].Antimicrob Agents Chemother,2010;54(4):1603-12.
5Moubareck C,Meziane-Cherif D,Courvalin P,et al.VanA-type Staphylococcus aureus strain VRSA-7 is partially dependent on ancomycin for growth[J].Antimicrob Agents Chemother,2009;53(9):3657-63.
7Lee JH.Occurrence of methicillilr resistant staphylococcus aures strains from cattle andchicken and analyses of their mecA,mecR1 and mecI genes[J].Vet Microbiol,2006;114(1-2):155-9.
6González-Zorn B,Courvalin P.VanA-mediated high level glycopeptide resistance in MRSA[J].Lancet Infect Dis,2003,3:67-68.
7Lee JH.Occurrence of methicillin-resistant Staphylococcus aureus strains from cattle and chicken,and analyses of their mecA,mecR1 and mecI genes[J].Vet Microbiol,2005,17:1-5.
8Clark NC,Weigel LM,Patel JB,et al.Comparison of Tn1546-like elements in vancomycin-resistant Staphylococcus aureus isolates from Michigan and Pennsylvania[J].Antimicrob Agents Chemother,2005,49(1):470-472.
9Mlynarczyk A,Mlynarczyk G,Luczak M.Conjugative transfer of glycopeptide and macrolide resistant genes among enterococci and from Enterococcus faecalis to Staphylococcus aureus[J].Med Dosw Mikrobiol,2002,54(1):21-28.
10Apfalter P.MRSA/MRSE-VISA/GISA/VRSA-PRP-VRE:current Gram positive bacteria problem and mechanism of resistance,prevalence and clinical consequences[J].Wien Med Wochenschr,2003,153(7-8):144-147.
2Wolska K, szwedap.Genetic features of clinical Pseudomonas aerugi- nosa strains [J].Pol J Mierebiol, 2009,58(3) : 255-260.
3Goolz TD.The forgolten Gram-negative bacilli: what genetic deter minants are telling as about the spread of antibiotic resistance [J]. Biochem pharmacol,2006,71 (7): 1073-1084.
4YangQW,WangH,SunHI,etal. Phenotypic andgenotypic character- ization of Enterobacteriaceae with decreased susceptibility tocarbapen- eros : results from largehospitalbased surveillance studies in China [J]. Antimicrob Agents Chemother, 2010,54(1) : 573-577.
